BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings41.5x
CheapRich

Above its usual level · 68th percentile, 5-year average 29.8x

#2447 of 2994 stocks by PE (1 = cheapest)

Price / book6.3x
CheapRich

Above its usual level · 74th percentile, 5-year average 5.1x

#4611 of 5331 stocks by PB (1 = cheapest)

Price / sales19.2x
CheapRich

Above its usual level · 61st percentile, 5-year average 37.8x

#4718 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-158x64x286x507xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$294.79
Price vs. fair value+4.8%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.30 – 5.12 74% (pricier than usual) #4611 of 5331 (1 = cheapest)
PE 41.47 32.45 29.75 68% (pricier than usual) #2447 of 2994 (1 = cheapest)
PS 19.24 15.42 37.84 61% (pricier than usual) #4718 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top